RYH - Invesco S&P 500 Equal Weight Health Care ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
+1.44 (+0.72%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close201.09
Bid202.52 x 1100
Ask202.46 x 1100
Day's Range200.87 - 202.66
52 Week Range165.66 - 207.73
Avg. Volume23,853
Net Assets760.49M
PE Ratio (TTM)N/A
YTD Return13.39%
Beta (3Y Monthly)1.15
Expense Ratio (net)0.40%
Inception Date2006-11-01
Trade prices are not sourced from all markets
  • Estimates and Recommendations for DaVita on September 17
    Market Realist10 months ago

    Estimates and Recommendations for DaVita on September 17

    Wall Street analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017. Its adjusted EPS is estimated at $4 in 2018 compared to $3.32 in 2017. Analysts estimate that its net adjusted income will increase to $693.4 million in 2018 compared to $634.9 million in 2017.

  • We're sorry this is all we were able to find about this topic.